New Treatment Options in Multiple Myeloma, February 2013 - Learn about some of the latest breakthrough treatments in multiple myeloma such as Pomalyst (pomalidomide), Kyprolis (carfilzomib), and subcutaneous Velcade (bortezomib) from our panel of experts.

Highlights From the 13th International Myeloma Workshop

The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.